Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mostly higher, with the Dow Jones index gaining around 100 points on Thursday.Shares of Methode Electronics, Inc. (NYSE:MEI) rose sharply during Thursday's session after the company

BenzingaJul 11 10:10 ET

Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Stocks Loved by Analysts?

Yahoo FinanceJul 8 18:46 ET

H.C. Wainwright Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $32

H.C. Wainwright analyst Joseph Pantginis maintains $Iovance Biotherapeutics(IOVA.US)$ with a buy rating, and maintains the target price at $32.According to TipRanks data, the analyst has a success rat

Moomoo NewsJun 28 11:31 ET · Ratings

Is It Too Late to Buy Iovance Biotherapeutics Stock?

Yahoo FinanceJun 28 04:05 ET

Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma

First of Multiple Planned Global Submissions for Lifileucel in 2024 and 2025Key Step in Global Expansion to Address >20,000 Patients Annually with Previously Treated Advanced MelanomaSAN CARLOS, Calif

Iovance BiotherapeuticsJun 28 00:00 ET

Iovance Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., June 21, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company"), a biotechnology company focused on innovating, developing, and delive

Iovance BiotherapeuticsJun 21 00:00 ET